DIRECT ORAL ANTICOAGULANTS (DOACS) FOR OFF-LABEL USE IN PATIENTS WITH BUDD CHIARI SYNDROME (BCS)

Georg Semmler  1     Katharina Pomej  1     David Bauer  1     Benedikt Hofer  1     Lorenz Balcar  1     Benedikt Simbrunner  1     Matthias Pinter  1     Michael Trauner  2     Thomas Reiberger     Mattias Mandorfer     Bernhard Scheiner    
1 Medical University of Vienna,Vienna,Austria
2 Medical University

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing